Integrase, LEDGF/p75 and HIV replication

Cellular and Molecular Life Sciences

Volumn 65, Issue 9, 2008, Pages 1403-1424

  Poeschla, E M ^a  

^a MAYO CLINIC   (United States)

Author keywords

AT Hook; Chromatin; HIV; HRP 2; Integrase; Integration; LEDGF p75; Lentivirus; PWWP domain

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; HEPATOMA DERIVED GROWTH FACTOR; INTEGRASE; INTEGRATION HOST FACTOR; LENS EPITHELIUM DERIVED GROWTH FACTOR; LENTIVIRUS VECTOR; PROTEIN P75; RALTEGRAVIR; VIRUS VECTOR;

ANTIVIRAL ACTIVITY; CELL FUNCTION; ENZYME ACTIVITY; GENE THERAPY; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; LIFE CYCLE; MEDICAL RESEARCH; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; GENE THERAPY; GENETIC VECTORS; HIV INTEGRASE; HIV-1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; VIRUS INTEGRATION; VIRUS REPLICATION;

LENTIVIRUS;

EID: 43049182995     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-7540-5     Document Type: Review

References (206)

1. Han, Y., Wind-Rotolo, M., Yang, H. C., Siliciano, J. D. and Siliciano, R. F. (2007). Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5, 95-106.
2. Bisgrove, D., Lewinski, M., Bushman, F. and Verdin, E. (2005). Molecular mechanisms of HIV-1 proviral latency. Expert Rev. Anti. Infect. Ther. 3, 805-814.
3. Hazuda, D. J., Young, S. D., Guare, J. P., Anthony, N. J., Gomez, R. P., Wai, J. S., Vacca, J. P., Handt, L., Motzel, S. L., Klein, H. J., Dornadula, G., Danovich, R. M., Witmer, M. V., Wilson, K. A., Tussey, L., Schleif, W. A., Gabryelski, L. S., Jin, L., Miller, M. D., Casimiro, D. R., Emini, E. A. and Shiver, J. W. (2004). Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 305, 528-532.
4. Grinsztejn, B., Nguyen, B. Y., Katlama, C., Gatell, J. M., Lazzarin, A., Vittecoq, D., Gonzalez, C. J., Chen, J., Harvey, C. M. and Isaacs, R. D. (2007). Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial. Lancet 369, 1261-1269.
5. Brown, P. O., Bowerman, B., Varmus, H. E. and Bishop, J. M. (1987). Correct integration of retroviral DNA in vitro. Cell 49, 347-356.
6. Craigie, R., Fujiwara, T. and Bushman, F. (1990). The IN protein of Moloney murine leukemia virus processes the viral DNAends and accomplishes their integration in vitro. Cell 62, 829-837.
7. Engelman, A., Mizuuchi, K. and Craigie, R. (1991). HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67, 1211-1221.
8. Brown, P. O. (1999) Integration. In: Retroviruses Coffin, J. M., Hughes, S. H. and Varmus, H. E., (eds.), pp. 161-203, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
9. Craigie, R. (2001). HIV integrase, a brief overview from chemistry to therapeutics. J. Biol. Chem. 276, 23213-23216.
10. Skalka, A. M. and Katz, R. A. (2005). Retroviral DNA integration and the DNA damage response. Cell Death Differ. 12 Suppl. 1, 971-978.
11. Bushman, F. D., Fujiwara, T. and Craigie, R. (1990). Retroviral DNA integration directed by HIV integration protein in vitro. Science 249, 1555-1558.
12. Katz, R. A., Merkel, G., Kulkosky, J., Leis, J. and Skalka, A. M. (1990). The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63, 87-95.
13. Vora, A. C., Fitzgerald, M. L. and Grandgenett, D. P. (1990). Removal of 3′-OH-terminal nucleotides from blunt-ended long terminal repeat termini by the avian retrovirus integration protein. J. Virol. 64, 5656-5659.
14. Bushman, F. D. and Craigie, R. (1991). Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88, 1339-1343.
15. Bowerman, B., Brown, P. O., Bishop, J. M. and Varmus, H. E. (1989). A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3, 469-478.
16. Ellison, V., Abrams, H., Roe, T., Lifson, J. and Brown, P. (1990). Human immunodeficiency virus integration in a cell-free system. J. Virol. 64, 2711-2715.
17. Farnet, C. M. and Haseltine, W. A. (1990). Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 87, 4164-4168.
18. Bukrinsky, M. I., Sharova, N., McDonald, T. L., Pushkarskaya, T., Tarpley, W. G. and Stevenson, M. (1993). Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Nat. Acad. Sci. USA 90, 6125-6129.
19. Miller, M. D., Farnet, C. M. and Bushman, F. D. (1997). Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71, 5382-5390.
20. Phair, R. D., Scaffidi, P., Elbi, C., Vecerova, J., Dey, A., Ozato, K., Brown, D. T., Hager, G., Bustin, M. and Misteli, T. (2004). Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol. Cell. Biol. 24, 6393-6402.
21. Catez, F., Ueda, T. and Bustin, M. (2006). Determinants of histone H1 mobility and chromatin binding in living cells. Nat. Struct. Mol. Biol. 13, 305-310.
22. Fassati, A. and Goff, S. P. (2001). Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75, 3626-3635.
23. Suzuki, Y. and Craigie, R. (2007). The road to chromatin - nuclear entry of retroviruses. Nat. Rev. Microbiol. 5, 187-196.
24. Sheehy, A. M., Gaddis, N. C., Choi, J. D. and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
25. Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J. and Bieniasz, P. D. (2003). Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9, 1138-1143.
26. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. and Sodroski, J. (2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
27. Bieniasz, P. D. (2004). Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5, 1109-1115.
28. Sokolskaja, E. and Luban, J. (2006). Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr. Opin. Microbiol. 9, 404-408.
29. Goff, S. P. (2007). Host factors exploited by retroviruses. Nat. Rev. Microbiol. 5, 253-263.
30. Bushman, F. D. (1999). Host proteins in retroviral cDNA integration. Adv. Virus Res. 52, 301-317.
31. Engelman, A. (2003). The roles of cellular factors in retroviral integration. Curr. Top. Microbiol. Immunol. 281, 209-238.
32. Sorin, M. and Kalpana, G. V. (2006). Dynamics of virus-host interplay in HIV-1 replication. Curr. HIV Res. 4, 117-130.
33. Van Maele, B., Busschots, K., Vandekerckhove, L., Christ, F. and Debyser, Z. (2006). Cellular cofactors of HIV-1 integration. Trends Biochem. Sci. 31, 98-105.
34. Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R. and Bushman, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
35. Wu, X., Li, Y., Crise, B. and Burgess, S. M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.
36. Narezkina, A., Taganov, K. D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A. M. and Katz, R. A. (2004). Genome-wide analyses of avian sarcoma virus integration sites. J. Virol. 78, 11656-11663.
37. Mitchell, R. S., Beitzel, B. F., Schroder, A. R., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R. and Bushman, F. D. (2004). Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences. PLoS Biol. 2, E234.
38. Hematti, P., Hong, B. K., Ferguson, C., Adler, R., Hanawa, H., Sellers, S., Holt, I. E., Eckfeldt, C. E., Sharma, Y., Schmidt, M. et al. (2004). Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2, e423.
39. Crise, B., Li, Y., Yuan, C., Morcock, D. R., Whitby, D., Munroe, D. J., Arthur, L. O. and Wu, X. (2005). Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 79, 12199-12204.
40. Maxfield, L. F., Fraize, C. D. and Coffin, J. M. (2005). Relationship between retroviral DNA-integration-site selection and host cell transcription. Proc. Natl. Acad. Sci. USA 102, 1436-1441.
41. Bushman, F., Lewinski, M., Ciuffi, A., Barr, S., Leipzig, J., Hannenhalli, S. and Hoffmann, C. (2005). Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3, 848-858.
42. Barr, S. D., Leipzig, J., Shinn, P., Ecker, J. R. and Bushman, F. D. (2005). Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J. Virol. 79, 12035-12044.
43. Kang, Y., Moressi, C. J., Scheetz, T. E., Xie, L., Tran, D. T., Casavant, T. L., Ak, P., Benham, C. J., Davidson, B. L. and McCray, P. B., Jr. (2006). Integration site choice of a feline immunodeficiency virus vector. J. Virol. 80, 8820-8823.
44. Ciuffi, A., Mitchell, R. S., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R. and Bushman, F. D. (2006). Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol. Ther. 13, 366-373.
45. MacNeil, A., Sankale, J. L., Meloni, S. T., Sarr, A. D., Mboup, S. and Kanki, P. (2006). Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. J. Virol. 80, 7316-7321.
46. Hacker, C. V., Vink, C. A., Wardell, T. W., Lee, S., Treasure, P., Kingsman, S. M., Mitrophanous, K. A. and Miskin, J. E. (2006). The integration profile of EIAV-based vectors. Mol. Ther. 14, 536-545.
47. Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., Berka, J., Braverman, M. S., Chen, Y. J., Chen, Z. et al. (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376-380.
48. Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C. and Bushman, F. D. (2007). HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. Published online before print, 1 June.
49. Pryciak, P. M., Sil, A. and Varmus, H. E. (1992). Retroviral integration into minichromosomes in vitro. EMBO J. 11, 291-303.
50. Pryciak, P. M. and Varmus, H. E. (1992). Nucleosomes, DNA binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69, 769-780.
51. Pruss, D., Bushman, F. D. and Wolffe, A. P. (1994). Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Nat. Acad. Sci. USA 91, 5913-5917.
52. Pruss, D., Reeves, R., Bushman, F. D. and Wolffe, A. P. (1994). The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 269, 25031-25041.
53. Muller, H. P. and Varmus, H. E. (1994). DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J. 13, 4704-4714.
54. Withers-Ward, E. S., Kitamura, Y., Barnes, J. P. and Coffin, J. M. (1994). Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev. 8, 1473-1487.
55. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W. et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
56. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A. et al. (2001). The sequence of the human genome. Science 291, 1304-1351.
57. Faschinger, A., Rouault, F., Sollner, J., Lukas, A., Salmons, B., Gunzburg, W. H. and Indik, S. (2008). Mouse mammary tumor virus integration site selection in human and mouse genomes. J. Virol. 82, 1360-1367.
58. Nowrouzi, A., Dittrich, M., Klanke, C., Heinkelein, M., Rammling, M., Dandekar, T., von Kalle, C. and Rethwilm, A. (2006). Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87, 1339-1347.
59. Trobridge, G. D., Miller, D. G., Jacobs, M. A., Allen, J. M., Kiem, H. P., Kaul, R. and Russell, D. W. (2006). Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. USA 103, 1498-1503.
60. Bushman, F. D. (2002). Integration site selection by lentiviruses: biology and possible control. Curr. Top. Microbiol. Immunol. 261, 165-177.
61. Carteau, S., Hoffmann, C. and Bushman, F. (1998). Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol. 72, 4005-4014.
62. Jordan, A., Bisgrove, D. and Verdin, E. (2003). HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868-1877.
63. Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R. and Bushman, F. D. (2005). Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79, 6610-6619.
64. Ge, H., Si, Y. and Roeder, R. G. (1998). Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J. 17, 6723-6729.
65. Ge, H., Si, Y. and Wolffe, A. P. (1998). A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol. Cell 2, 751-759.
66. Singh, D. P., Ohguro, N., Chylack, L. T., Jr. and Shinohara, T. (1999). Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses. Invest. Ophthalmol. Vis. Sci. 40, 1444-1451.
67. Sharma, P., Singh, D. P., Fatma, N., Chylack, L. T., Jr. and Shinohara, T. (2000). Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem. Biophys. Res. Commun. 276, 1320-1324.
68. Singh, D. P., Fatma, N., Kimura, A., Chylack, L. T., Jr. and Shinohara, T. (2001). LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes. Biochem. Biophys. Res. Commun. 283, 943-955.
69. Nishizawa, Y., Usukura, J., Singh, D. P., Chylack, L. T., Jr. and Shinohara, T. (2001). Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleus. Cell Tissue Res. 305, 107-114.
70. Fatma, N., Singh, D. P., Shinohara, T. and Chylack, L. T., Jr. (2001). Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress. J. Biol. Chem. 276, 48899-48907.
71. Wu, X., Daniels, T., Molinaro, C., Lilly, M. B. and Casiano, C. A. (2002). Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders. Cell Death Differ. 9, 915-925.
72. Ganapathy, V., Daniels, T. and Casiano, C. A. (2003). LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun. Rev. 2, 290-297.
73. Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E. and Debyser, Z. (2003). HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278, 372-381.
74. Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z. and Engelborghs, Y. (2003). LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 278, 33528-33539.
75. Llano, M., Vanegas, M., Fregoso, O., Saenz, D. T., Chung, S., Peretz, M. and Poeschla, E. M. (2004). LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral pre-integration complexes. J. Virol. 78, 9524-9537.
76. Turlure, F., Devroe, E., Silver, P. A. and Engelman, A. (2004). Human cell proteins and human immunodeficiency virus DNA integration. Front. Biosci. 9, 3187-3208.
77. Maertens, G., Cherepanov, P., Debyser, Z., Engelborghs, Y. and Engelman, A. (2004). Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase (IN) interactor LEDGF/p75. J. Biol. Chem. 279, 33421-33429.
78. Llano, M., Delgado, S., Vanegas, M. and Poeschla, E. M. (2004). LEDGF/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 279, 55570-55577.
79. Cherepanov, P., Devroe, E., Silver, P. A. and Engelman, A. (2004). Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional coactivator p75 (LEDGF/p75) that binds HIV-1 integrase. J. Biol. Chem. 279, 48883-48892.
80. Vanegas, M., Llano, M., Delgado, S., Thompson, D., Peretz, M. and Poeschla, E. (2005). Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell Sci. 118, 1733-1743.
81. Cherepanov, P., Sun, Z. Y., Rahman, S., Maertens, G., Wagner, G. and Engelman, A. (2005). Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat. Struct. Mol. Biol. 12, 526-532.
82. Cherepanov, P., Ambrosio, A. L., Rahman, S., Ellenberger, T. and Engelman, A. (2005). Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. USA 102, 17308-17313.
83. Bradley, C. M. and Craigie, R. (2005). Seeing is believing: structure of the catalytic domain of HIV-1 integrase in complex with human LEDGF/p75. Proc. Natl. Acad. Sci. USA 102, 17543-17544.
84. Daniels, T., Zhang, J., Gutierrez, I., Elliot, M. L., Yamada, B., Heeb, M. J., Sheets, S. M., Wu, X. and Casiano, C. A. (2005). Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 62, 14-26.
85. Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R. and Bushman, F. (2005). A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11, 1287-1289.
86. Emiliani, S., Mousnier, A., Busschots, K., Maroun, M., Van Maele, B., Tempe, D., Vandekerckhove, L., Moisant, F., Ben-Slama, L., Witvrouw, M. et al. (2005). Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J. Biol. Chem. 280, 25517-25523.
87. Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F. and Debyser, Z. (2005). The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem. 280, 17841-17847.
88. Maertens, G., Vercammen, J., Debyser, Z. and Engelborghs, Y. (2005). Measuring protein-protein interactions inside living cells using single color fluorescence correlation spectroscopy. Application to human immunodeficiency virus type 1 integrase and LEDGF/p75. FASEB J. 19, 1039-1041.
89. Turlure, F., Maertens, G., Rahman, S., Cherepanov, P. and Engelman, A. (2006). A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res. 34, 1663-1675.
90. Vandegraaff, N., Devroe, E., Turlure, F., Silver, P. A. and Engelman, A. (2006). Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology 346, 415-426.
91. Zielske, S. and Stevenson, M. (2006). Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J. Virol. 80, 7275-7280.
92. Ciuffi, A. and Bushman, F. D. (2006). Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet. 22, 388-395.
93. Llano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S. and Poeschla, E. M. (2006). Identification and characterization of the chromatin binding domains of the HIV-1 integrase interactor LEDGF/p75. J. Mol. Biol. 360, 760-773.
94. Sutherland, H. G., Newton, K., Brownstein, D. G., Holmes, M. C., Kress, C., Semple, C. A. and Bickmore, W. A. (2006). Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol. Cell. Biol. 26, 7201-7210.
95. Vandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M. and Debyser, Z. (2006). Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80, 1886-1896.
96. Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W. and Poeschla, E. M. (2006). An Essential Role for LEDGF/p75 in HIV Integration. Science 314, 461-464.
97. De Rijck, J., Vandekerckhove, L., Gijsbers, R., Hombrouck, A., Hendrix, J., Vercammen, J., Engelborghs, Y., Christ, F. and Debyser, Z. (2006). Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J. Virol. 80, 11498-11509.
98. Maertens, G. N., Cherepanov, P. and Engelman, A. (2006). Transcriptional coactivator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin. J. Cell Sci. 119, 2563-2571.
99. Bartholomeeusen, K., De Rijck, J., Busschots, K., Desender, L., Gijsbers, R., Emiliani, S., Benarous, R., Debyser, Z. and Christ, F. (2007). Differential Interaction of HIV-1 Integrase and JPO2 with the C Terminus of LEDGF/p75. J. Mol. Biol. 372, 407-421.
100. Cherepanov, P. (2007). LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res. 35, 113-124.
101. Shun, M. C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P. and Engelman, A. (2007). LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 21, 1767-1778.
102. Busschots, K., Voet, A., De Maeyer, M., Rain, J. C., Emiliani, S., Benarous, R., Desender, L., Debyser, Z. and Christ, F. (2007). Identification of the LEDGF/p75 binding site in HIV-1 integrase. J. Mol. Biol. 365, 1480-1492.
103. Pandey, K. K., Sinha, S. and Grandgenett, D. P. (2007). Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration. J. Virol. 81, 3969-3979.
104. Raghavendra, N. K. and Engelman, A. (2007). LEDGF/p75 interferes with the formation of synaptic nucleoprotein complexes that catalyze full-site HIV-1 DNA integration in vitro: implications for the mechanism of viral cDNA integration. Virology 360, 1-5.
105. Rahman, S., Lu, R., Vandegraaff, N., Cherepanov, P. and Engelman, A. (2007). Structure-based mutagenesis of the integrase-LEDGF/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness. Virology 357, 79-90.
106. Hayouka, Z., Rosenbluh, J., Levin, A., Loya, S., Lebendiker, M., Veprintsev, D., Kotler, M., Hizi, A., Loyter, A. and Friedler, A. (2007). Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc. Natl. Acad. Sci. USA 104, 8316-8321.
107. Huang, T. S., Myklebust, L. M., Kjarland, E., Gjertsen, B. T., Pendino, F., Bruserud, O., Doskeland, S. O. and Lillehaug, J. R. (2007). LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol. Cancer 6, 31.
108. Yu, F., Jones, G. S., Hung, M., Wagner, A. H., MacArthur, H. L., Liu, X., Leavitt, S., McDermott, M. J. and Tsiang, M. (2007). HIV-1 integrase preassembled on donor DNA is refractory to activity stimulation by LEDGF/p75. Biochemistry 46, 2899-2908.
109. Hombrouck, A., De Rijck, J., Hendrix, J., Vandekerckhove, L., Voet, A., Maeyer, M. D., Witvrouw, M., Engelborghs, Y., Christ, F., Gijsbers, R. et al. (2007). Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog. 3, e47.
110. Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E. and Bushman, F. D. (2007). Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS ONE 2, e1340.
111. Kulkosky, J. and Skalka, A. M. (1994). Molecular mechanism of retroviral DNA integration. Pharmacol. Ther. 61, 185-203.
112. Andrake, M. D. and Skalka, A. M. (1996). Retroviral integrase, putting the pieces together. J. Biol. Chem. 271, 19633-19636.
113. Esposito, D. and Craigie, R. (1999). HIV integrase structure and function. Adv. Virus Res. 52, 319-333.
114. Asante-Appiah, E. and Skalka, A. M. (1999). HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv. Virus Res. 52, 351-369.
115. Chiu, T. K. and Davies, D. R. (2004). Structure and function of HIV-1 integrase. Curr. Top. Med. Chem. 4, 965-977.
116. Grandgenett, D. P. (2005). Symmetrical recognition of cellular DNA target sequences during retroviral integration. Proc. Natl. Acad. Sci. USA 102, 5903-5904.
117. Lewinski, M. K. and Bushman, F. D. (2005). Retroviral DNA integration - mechanism and consequences. Adv. Genet. 55, 147-181.
118. Gallay, P., Hope, T., Chin, D. and Trono, D. (1997). HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94, 9825-9830.
119. Pluymers, W., Cherepanov, P., Schols, D., De Clercq, E. and Debyser, Z. (1999). Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. Virology 258, 327-332.
120. Petit, C., Schwartz, O. and Mammano, F. (1999). Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase. J. Virol. 73, 5079-5088.
121. Petit, C., Schwartz, O. and Mammano, F. (2000). The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J. Virol. 74, 7119-7126.
122. Cherepanov, P., Pluymers, W., Claeys, A., Proost, P., De Clercq, E. and Debyser, Z. (2000). High-level expression of active HIV-1 integrase from a synthetic gene in human cells. FASEB J. 14, 1389-1399.
123. Devroe, E., Engelman, A. and Silver, P. A. (2003). Intracellular transport of human immunodeficiency virus type 1 integrase. J. Cell Sci. 116, 4401-4408.
124. Fassati, A. (2006). HIV infection of non-dividing cells: a divisive problem. Retrovirology 3, 74.
125. Kukolj, G., Jones, K. S. and Skalka, A. M. (1997). Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. J. Virol. 71, 843-847.
126. Roe, T., Reynolds, T. C., Yu, G. and Brown, P. O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
127. Lewis, P. F. and Emerman, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516.
128. Dvorin, J. D., Bell, P., Maul, G. G., Yamashita, M., Emerman, M. and Malim, M. H. (2002). Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J. Virol. 76, 12087-12096.
129. Limon, A., Devroe, E., Lu, R., Ghory, H. Z., Silver, P. A. and Engelman, A. (2002). Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J. Virol. 76, 10598-10607.
130. Yamashita, M. and Emerman, M. (2004). Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 78, 5670-5678.
131. Yamashita, M. and Emerman, M. (2005). The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog. 1, e18.
132. Dismuke, D. J. and Aiken, C. (2006). Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 80, 3712-3720.
133. Yamashita, M., Perez, O., Hope, T. J. and Emerman, M. (2007). Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog. 3, 1502-1510.
134. Stec, I., Nagl, S. B., van Ommen, G. J. and den Dunnen, J. T. (2000). The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett. 473, 1-5.
135. Qiu, C., Sawada, K., Zhang, X. and Cheng, X. (2002). The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds. Nat. Struct. Biol. 9, 217-224.
136. Berry, C., Hannenhalli, S., Leipzig, J. and Bushman, F. D. (2006). Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol. 2, e157.
137. Izumoto, Y., Kuroda, T., Harada, H., Kishimoto, T. and Nakamura, H. (1997). Hepatoma-derived growth factor belongs to a gene family in mice showing significant homology in the amino terminus. Biochem. Biophys. Res. Commun. 238, 26-32.
138. Ikegame, K., Yamamoto, M., Kishima, Y., Enomoto, H., Yoshida, K., Suemura, M., Kishimoto, T. and Nakamura, H. (1999). A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus. Biochem. Biophys. Res. Commun. 266, 81-87.
139. van de Wetering, M., Oosterwegel, M., van Norren, K. and Clevers, H. (1993). Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 12, 3847-3854.
140. Smith, C. A., Bates, P., Rivera-Gonzalez, R., Gu, B. and DeLuca, N. A. (1993). ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J. Virol. 67, 4676-4687.
141. Wu, C. L. and Wilcox, K. W. (1991). The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters. J. Virol. 65, 1149-1159.
142. Perera, L. P., Mosca, J. D., Ruyechan, W. T., Hayward, G. S., Straus, S. E. and Hay, J. (1993). A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain. J. Virol. 67, 4474-4483.
143. Meier, U. T. and Blobel, G. (1992). Nopp140 shuttles on tracks between nucleolus and cytoplasm. Cell 70, 127-138.
144. Ge, H. and Roeder, R. G. (1994). Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 78, 513-523.
145. Mulder, L. C. and Muesing, M. A. (2000). Degradation of HIV-1 integrase by the N-end rule pathway. J. Biol. Chem. 275, 29749-29753.
146. Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F. and Heard, J. M. (1998). Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72, 3845-3850.
147. Butler, S. L., Johnson, E. P. and Bushman, F. D. (2002). Human immunodeficiency virus cDNA metabolism: notable stability of two- long terminal repeat circles. J. Virol. 76, 3739-3747.
148. Mousnier, A., Kubat, N., Massias-Simon, A., Segeral, E., Rain, J. C., Benarous, R., Emiliani, S. and Dargemont, C. (2007). von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc. Natl. Acad. Sci. USA 104, 13615-13620.
149. Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S. et al. (2006). Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2, e60.
150. Ciuffi, A., Diamond, T. L., Hwang, Y., Marshall, H. M. and Bushman, F. D. (2006). Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum. Gene Ther. 17, 960-967.
151. Engelman, A. (1999). In vivo analysis of retroviral integrase structure and function. Adv. Virus Res. 52, 411-426.
152. (2003). Whither RNAi? Nat. Cell. Biol. 5, 489-490.
153. Llano, M., Gaznick, N. and Poeschla, E. M. (2007) Rapid, controlled and intensive lentiviral vector-based RNAi. In: HIV Protocols, 2nd edn Kalpana, G. and Prasad, V. (eds.), Humana Press, Totowa, NJ, in press.
154. Li, M., Mizuuchi, M., Burke, T. R., Jr. and Craigie, R. (2006). Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J. 25, 1295-1304.
155. Sinha, S. and Grandgenett, D. P. (2005). Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J. Virol. 79, 8208-8216.
156. Li, M. and Craigie, R. (2005). Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J. Biol. Chem. 280, 29334-29339.
157. Faure, A., Calmels, C., Desjobert, C., Castroviejo, M., Caumont-Sarcos, A., Tarrago-Litvak, L., Litvak, S. and Parissi, V. (2005). HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res. 33, 977-986.
158. Guiot, E., Carayon, K., Delelis, O., Simon, F., Tauc, P., Zubin, E., Gottikh, M., Mouscadet, J. F., Brochon, J. C. and Deprez, E. (2006). Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J. Biol. Chem. 281, 22707-22719.
159. Cremer, T., Cremer, M., Dietzel, S., Muller, S., Solovei, I. and Fakan, S. (2006). Chromosome territories - a functional nuclear landscape. Curr. Opin. Cell Biol. 18, 307-316.
160. Jacque, J. M. and Stevenson, M. (2006). The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature 441, 641-645.
161. Shun, M. C., Daigle, J. E., Vandegraaff, N. and Engelman, A. (2007). Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein. J. Virol. 81, 166-172.
162. Holman, A. G. and Coffin, J. M. (2005). Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. USA 102, 6103-6107.
163. Wu, X., Li, Y., Crise, B., Burgess, S. M. and Munroe, D. J. (2005). Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J. Virol. 79, 5211-5214.
164. Arkin, M. R. and Wells, J. A. (2004). Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat. Rev. Drug Discov. 3, 301-317.
165. Wells, J. A. and McClendon, C. L. (2007). Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001-1009.
166. Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C. et al. (2004). In vivo activation of the p53 pathway by smallmolecule antagonists of MDM2. Science 303, 844-848.
167. He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C. et al. (2005). Small-molecule inhibition of TNF-alpha. Science 310, 1022-1025.
168. Molteni, V., Greenwald, J., Rhodes, D., Hwang, Y., Kwiatkowski, W., Bushman, F. D., Siegel, J. S. and Choe, S. (2001). Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. Acta Crystallogr. D Biol. Crystallogr. 57, 536-544.
169. Al-Mawsawi, L. Q., Fikkert, V., Dayam, R., Witvrouw, M., Burke, T. R., Jr., Borchers, C. H. and Neamati, N. (2006). Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc. Natl. Acad. Sci. USA 103, 10080-10085.
170. Naldini, L., Bloemer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M. and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
171. Poeschla, E., Wong-Staal, F. and Looney, D. (1998). Efficient transduction of nondividing cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4, 354-357.
172. Olsen, J. C. (1998). Gene transfer vectors derived from equine infectious anemia virus. Gene Ther. 5, 1481-1487.
173. Loewen, N. and Poeschla, E. M. (2005). Lentiviral vectors. Adv. Biochem. Eng. Biotechnol. 99, 169-191.
174. Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., Moen, R. et al. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176, 1125-1135.
175. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E. et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
176. Pike-Overzet, K., van der Burg, M., Wagemaker, G., van Dongen, J. J. and Staal, F. J. (2007). New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol. Ther. 15, 1910-1916.
177. Holmes-Son, M. L. and Chow, S. A. (2002). Correct integration mediated by integrase-LexA fusion proteins incorporated into HIV-1. Mol. Ther. 5, 360-370.
178. Tan, W., Dong, Z., Wilkinson, T. A., Barbas, C. F., 3rd and Chow, S. A. (2006). Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells. J. Virol. 80, 1939-1948.
179. Craigie, R. (1992). Hotspots and warm spots: integration specificity of retroelements. Trends Genet. 8, 187-190.
180. Zou, S., Ke, N., Kim, J. M. and Voytas, D. F. (1996). The Saccharomyces retrotransposon Ty5 integrates preferentially into regions of silent chromatin at the telomeres and mating loci. Genes Dev. 10, 634-645.
181. Xie, W., Gai, X., Zhu, Y., Zappulla, D. C., Sternglanz, R. and Voytas, D. F. (2001). Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol. Cell. Biol. 21, 6606-6614.
182. Dai, J., Xie, W., Brady, T. L., Gao, J. and Voytas, D. F. (2007). Phosphorylation regulates integration of the yeast Ty5 retrotransposon into heterochromatin. Mol. Cell 27, 289-299.
183. Zhu, Y., Dai, J., Fuerst, P. G. and Voytas, D. F. (2003). Controlling integration specificity of a yeast retrotransposon. Proc. Natl. Acad. Sci. USA 100, 5891-5895.
184. Sandmeyer, S. (2003). Integration by design. Proc. Natl. Acad. Sci. USA 100, 5586-5588.
185. McClintock, B. (1984). The significance of responses of the genome to challenge. Science 226, 792-801.
186. Deininger, P. L. and Batzer, M. A. (2002). Mammalian retroelements. Genome Res. 12, 1455-1465.
187. Han, K., Konkel, M. K., Xing, J., Wang, H., Lee, J., Meyer, T. J., Huang, C. T., Sandifer, E., Hebert, K., Barnes, E. W. et al. (2007). Mobile DNA in Old World monkeys: a glimpse through the rhesus macaque genome. Science 316, 238-240.
188. Heuer, T. S. and Brown, P. O. (1998). Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. Biochemistry 37, 6667-6678.
189. Hindmarsh, P., Ridky, T., Reeves, R., Andrake, M., Skalka, A. M. and Leis, J. (1999). HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J. Virol. 73, 2994-3003.
190. Sinha, S., Pursley, M. H. and Grandgenett, D. P. (2002). Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J. Virol. 76, 3105-3113.
191. Fletcher, T. M., 3rd, Soares, M. A., McPhearson, S., Hui, H., Wiskerchen, M., Muesing, M. A., Shaw, G. M., Leavitt, A. D., Boeke, J. D. and Hahn, B. H. (1997). Complementation of integrase function in HIV-1 virions. EMBO J. 16, 5123-5138.
192. Wu, X., Liu, H., Xiao, H., Conway, J. A., Hunter, E. and Kappes, J. C. (1997). Functional RTand IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J. 16, 5113-5122.
193. Patel, P. H. and Preston, B. D. (1994). Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc. Natl. Acad. Sci. USA 91, 549-553.
194. Ellison, V. and Brown, P. O. (1994). A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc. Natl. Acad. Sci. USA 91, 7316-7320.
195. Vora, A. C. and Grandgenett, D. P. (1995). Assembly and catalytic properties of retrovirus integrase-DNA complexes capable of efficiently performing concerted integration. J. Virol. 69, 7483-7488.
196. Brin, E., Yi, J., Skalka, A. M. and Leis, J. (2000). Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration. J. Biol. Chem. 275, 39287-39295.
197. Yoder, K. E. and Bushman, F. D. (2000). Repair of gaps in retroviral DNA integration intermediates. J. Virol. 74, 11191-11200.
198. Chow, S. A., Vincent, K. A., Ellison, V. and Brown, P. O. (1992). Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255, 723-726.
199. Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R. and Davies, D. R. (1994). Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266, 1981-1986.
200. Eijkelenboom, A. P., Lutzke, R. A., Boelens, R., Plasterk, R. H., Kaptein, R. and Hard, K. (1995). The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol. 2, 807-810.
201. Cai, M., Zheng, R., Caffrey, M., Craigie, R., Clore, G. M. and Gronenborn, A. M. (1997). Solution structure of the Nterminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol. 4, 567-577.
202. Goldgur, Y., Dyda, F., Hickman, A. B., Jenkins, T. M., Craigie, R. and Davies, D. R. (1998). Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA 95, 9150-9154.
203. Chen, J. C., Krucinski, J., Miercke, L. J., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D. and Stroud, R. M. (2000). Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. USA 97, 8233-8238.
204. Wang, J. Y., Ling, H., Yang, W. and Craigie, R. (2001). Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J. 20, 7333-7343.
205. Jenkins, T. M., Hickman, A. B., Dyda, F., Ghirlando, R., Davies, D. R. and Craigie, R. (1995). Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc. Natl. Acad. Sci. USA 92, 6057-6061.
206. Chiu, T. K. and Davies, D. R. (2007). Structure and function of HIV-1 integrase: an update. Fron. Med. Chem. 3, 1-20.